Navigation Links
Three Rivers Announces Positive Results from Phase 3 DIRECT Trial of Once-Daily INFERGEN(R) with Ribavirin in Hepatitis C Virus Treatment Failures
Date:6/16/2009

7% and 35.4% in the 9 mcg and 15 mcg arms. Regardless of treatment dose used, attaining viral negativity at Week 12 or at Week 24 while on therapy with INFERGEN and RBV leads to a high sustained virological response rate.

"These results represent a significant step forward for HCV patients who deserve a second chance at a potential cure for this chronic viral infection" stated Donald Kerrish, President and CEO of Three Rivers Pharmaceuticals.

Approximately 50% of patients with chronic hepatitis C fail to respond to their initial course of PEG-IFN/RBV therapy. No standard has yet emerged for second-line therapy, since simply repeating the same treatment, in well controlled trials, has yielded low response rates around 2-6%.

The DIRECT trial was a phase 3, randomized, open-label, multicenter, U.S.-based trial conducted to investigate the efficacy, tolerability, and safety of daily INFERGEN at dosages of 9 and 15 mcg/day administered with daily weight-based RBV. The study tested 2 dosages of INFERGEN in 487 documented non-responders, of which 80% did not achieve a 2-log drop on prior pegylated-interferon plus ribavirin therapy. The best SVR rates were seen in:

  • Patients achieving the greatest reduction in baseline viral load with peg-IFN/RBV therapy, especially in patients demonstrating > 1-log drop with initial therapy
  • Patients with fibrosis scores of F0 to F3 at baseline demonstrated SVRs of 7.8% in the 9 mcg arm and 13.1% in the 15 mcg arm
  • Patients maintaining full dose of INFERGEN/RBV therapy had SVRs of 7% and 17% for the 9 mcg and 15 mcg arms respectively
  • Patients demonstrating partial response (>2-log drop) with previous treatment and low fibrosis scores F0-F3 had SVRs of 10.7% and 31.6% for the 9 mcg and 15 mcg arms

Patients with cirrhosis were less likely to bene
'/>"/>

SOURCE Three Rivers Pharmaceuticals, LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Next Stage Solutions Announces Three New Financial Services For Emerging Business
2. AccuVein Inks National Three-Year Group Purchasing Deal With Amerinet
3. Oncothyreon announces clinical data from three product candidates presented at American Society of Clinical Oncology (ASCO) Annual Meeting
4. Trubion Announces Acceptance of Three Presentations on Its TRU-016 Product Candidate at the 2009 ASCO Annual Meeting
5. REG Signs Agreement with Three Biodiesel Plants to Consolidate
6. Three Attorneys Rejoin McKenna Long & Aldridge
7. Idenix Pharmaceuticals Reports Data From Three Hepatitis C Development Programs at the 44th Annual Meeting of the European Association for the Study of the Liver
8. WuXi AppTec Welcomes Three Senior Professionals
9. Idenix Announces Data Presentations from Three HCV Discovery and Development Programs at the 44th Annual Meeting of the European Association for the Study of the Liver (EASL)
10. Magellan to Receive Frost & Sullivan 2009 North American Product Innovation Award; Three-Minute LeadCare(R) II Test Identifies Children with Lead Poisoning
11. Three Firms, Two Training Programs Garner Greater Baltimore Committees 2009 Bioscience Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... , June 02, 2015 Research and ... "Genotyping Market by Technology, Application & by Products ... offering. The global genotyping market is expected ... in 2015, at a CAGR of 22.3% during the ... growth will be attributed to the availability of a ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 “Stem Cell Therapy ... more mainstream, and it is used often as an adjunct ... general practitioners are not yet aware or comfortable enough with ... therapy is most often reserved for the last resort cases ... pet can barely lift a paw to get around. It ...
(Date:6/2/2015)... , June 2, 2015  RXi ... biotechnology company focused on discovering and developing ... dermatology and ophthalmology, today announced that Dr. ... will present at the 23 rd ... world congress will include in-depth presentations by ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 Through rare ... technology, Yancy Corporation is enabling World Scientists ... material and biological sample, displaying the full nature (position, ... between atoms. , Jeff Porter, Co-Founder of the Yancy ... just that – rare. They come once in a ...
Breaking Biology Technology:Genotyping Market Report 2015 by Technology, Application & by Products - Global Forecast to 2020 for the $17 Billion Market 2VetStem Biopharma, Proudly Announces a New Long Term Partnership with VCA West Los Angeles in Support of Stem Cell Therapy Training and Clinical Opportunities. 2VetStem Biopharma, Proudly Announces a New Long Term Partnership with VCA West Los Angeles in Support of Stem Cell Therapy Training and Clinical Opportunities. 3RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 2RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 3RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 4Scientists Eying Rare Discovery Of New Physics & Light Microscope Technology 2
... , FT. MYERS, Fla., Sept. 3 NeoGenomics, ... present at the Rodman & Renshaw 11th Annual Healthcare Conference ... Palace Hotel in New York City. The conference will ... Senior executives of attending companies will make presentations to portfolio ...
... , , , NEW YORK, Sept. ... in its catalogue. , , Proteomics: Technologies ... http://www.reportlinker.com/p0132719/Proteomics-Technologies-and-Global-Markets.html , , REPORT ... for proteomics is expected to increase from $6.7 billion in 2008 to ...
... , , ... MASI ), the inventor of Pulse CO-Oximetry(TM) and Measure-Through ... Radical-7 and Rad-57 Pulse CO-Oximeters have achieved Airworthiness Release ... is a fundamental milestone that allows the U.S. military ...
Cached Biology Technology:NeoGenomics to Present at the Rodman & Renshaw Healthcare Investment Conference on September 10, 2009 2Reportlinker Adds Proteomics: Technologies and Global Markets Report 2Reportlinker Adds Proteomics: Technologies and Global Markets Report 3Reportlinker Adds Proteomics: Technologies and Global Markets Report 4Reportlinker Adds Proteomics: Technologies and Global Markets Report 5Reportlinker Adds Proteomics: Technologies and Global Markets Report 6Reportlinker Adds Proteomics: Technologies and Global Markets Report 7Reportlinker Adds Proteomics: Technologies and Global Markets Report 8Reportlinker Adds Proteomics: Technologies and Global Markets Report 9Reportlinker Adds Proteomics: Technologies and Global Markets Report 10Reportlinker Adds Proteomics: Technologies and Global Markets Report 11Reportlinker Adds Proteomics: Technologies and Global Markets Report 12Reportlinker Adds Proteomics: Technologies and Global Markets Report 13Reportlinker Adds Proteomics: Technologies and Global Markets Report 14Reportlinker Adds Proteomics: Technologies and Global Markets Report 15Reportlinker Adds Proteomics: Technologies and Global Markets Report 16Reportlinker Adds Proteomics: Technologies and Global Markets Report 17Reportlinker Adds Proteomics: Technologies and Global Markets Report 18Reportlinker Adds Proteomics: Technologies and Global Markets Report 19Reportlinker Adds Proteomics: Technologies and Global Markets Report 20Reportlinker Adds Proteomics: Technologies and Global Markets Report 21Masimo Radical-7(R) and Rad-57(R) Pulse CO-Oximeters(TM) Awarded Airworthiness Release Certification by the United States Army 2Masimo Radical-7(R) and Rad-57(R) Pulse CO-Oximeters(TM) Awarded Airworthiness Release Certification by the United States Army 3Masimo Radical-7(R) and Rad-57(R) Pulse CO-Oximeters(TM) Awarded Airworthiness Release Certification by the United States Army 4
(Date:5/19/2015)... Research and Markets ( ... the  "Genetic Testing Market Outlook 2018"  report ... ,A recent report, Genetic Testing Market Outlook ... current and future genetic testing market. A ... principles and types are covered in this ...
(Date:5/11/2015)... 11, 2015  Synaptics Incorporated (NASDAQ: SYNA ... today announced the appointment of Wajid Ali ... Officer, reporting to Rick Bergman , President ... Financial Officer, Kathleen Bayless , who announced ... Mr. Ali brings extensive financial management expertise to ...
(Date:5/8/2015)... 2015 Synaptics Inc. (NASDAQ: SYNA ), the ... of the executive management team will present at the following ... and Telecom Conference Date: May 18, 2015 Time: ... MA Cowen and Company Technology, Media ... Location: The New York Palace Hotel, New York, ...
Breaking Biology News(10 mins):Global Genetic Testing Market Outlook 2018 2Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2Synaptics to Present at Upcoming Investor Conferences 2
... Carnegie Mellon University graduate engineering students Shahzeen Attari, Ines ... are first-place winners in a letter-writing competition called Tomorrows ... ... Johnson Controls Inc., asked students to demonstrate their awareness ...
... night your cars headlights illuminate a deer in your path, ... other conditions, chances are good you will hit the deer. ... is fittingly defined as the collision mode, according to a ... PLoS Biology. The Northwestern researchers are the first to ...
... succeeded in reprogramming skin cells to behave like embryonic ... and ethical dynamics of the stem-cell debate, a leading ... and bioethics, says the scientific finding could have far-reaching ... over embryonic stem cell research. "This is a method ...
Cached Biology News:Carnegie Mellon students win contest 2Carnegie Mellon students win contest 3Northwestern study looks at sensing, movement and behavior 2Northwestern study looks at sensing, movement and behavior 3Reprogramming the debate: stem-cell finding alters ethical controversy 2Reprogramming the debate: stem-cell finding alters ethical controversy 3
... has over 23 years of experience in ... have made antibodies to large and small ... antigens, and plasmid DNA-encoded antigens. We understand ... so our hybridoma development programs are never ...
... The Rapid-Screen cDNA Library Panels were designed ... three sets of PCRs to identify the ... is performed in a 96-well "Master Plate," ... 5,000 clones. Having identified the positive well(s) ...
... The Rapid-Screen cDNA Library Panels were designed ... three sets of PCRs to identify the ... is performed in a 96-well "Master Plate," ... 5,000 clones. Having identified the positive well(s) ...
... Library Panels were designed for full-length gene ... PCRs to identify the desired cDNA clone. ... a 96-well "Master Plate," where each well ... identified the positive well(s) by gel electrophoresis ...
Biology Products: